PFAS
Basic information
Region (hg38): 17:8247618-8270491
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (159 variants)
- not_provided (8 variants)
- Phosphoribosylformylglycineamidine_synthase_deficiency (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PFAS gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012393.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 155 | 166 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 1 | 2 | 155 | 8 | 3 |
Highest pathogenic variant AF is 0.000400853
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PFAS | protein_coding | protein_coding | ENST00000314666 | 27 | 22874 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 9.85e-18 | 0.998 | 125626 | 0 | 122 | 125748 | 0.000485 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.961 | 756 | 834 | 0.906 | 0.0000528 | 8566 |
| Missense in Polyphen | 248 | 315.21 | 0.78679 | 3297 | ||
| Synonymous | -0.525 | 357 | 345 | 1.04 | 0.0000215 | 2891 |
| Loss of Function | 3.05 | 38 | 64.4 | 0.590 | 0.00000352 | 656 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000692 | 0.000689 |
| Ashkenazi Jewish | 0.000619 | 0.000595 |
| East Asian | 0.000707 | 0.000653 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.000606 | 0.000598 |
| Middle Eastern | 0.000707 | 0.000653 |
| South Asian | 0.000361 | 0.000359 |
| Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphoribosylformylglycinamidine synthase involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate (By similarity). {ECO:0000250}.;
- Pathway
- Purine metabolism - Homo sapiens (human);Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Metabolism of nucleotides;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;Purine ribonucleoside monophosphate biosynthesis;5-aminoimidazole ribonucleotide biosynthesis;purine nucleotides <i>de novo</i> biosynthesis
(Consensus)
Intolerance Scores
- loftool
- 0.865
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.22
Haploinsufficiency Scores
- pHI
- 0.786
- hipred
- Y
- hipred_score
- 0.578
- ghis
- 0.650
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.995
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Pfas
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; craniofacial phenotype; vision/eye phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- 'de novo' IMP biosynthetic process;glutamine metabolic process;purine ribonucleoside monophosphate biosynthetic process;response to drug;anterior head development
- Cellular component
- cytoplasm;cytosol;extracellular exosome
- Molecular function
- phosphoribosylformylglycinamidine synthase activity;ATP binding;metal ion binding